The existence of a common endodermal progenitor cell to both pancreas and liver is suggested by anatomy of the development of pancreatic and liver buds in embryogenesis. Here we review the large body of evidence that pancreas to liver and liver to pancreas cell differentiation can also occur in adult life. The published data are consistent with the hypothesis that endodermal progenitor cells, capable of giving rise to multiple hepatic and pancreatic cell types continue to persist. These cells may represent a stem cell reservoir with potential in cell therapy applications in the future. q
Adult liver stem cells
In adult mammals, the liver has the highest regenerative capacity of all parenchymal organs. Animals (including humans) can survive surgical removal of up to 75% of the total liver mass. The original number of cells is restored within 1 week and the original tissue mass within 2-3 weeks (Bucher and Swaffield, 1964; Stocker and Pfeifer, 1965) . This process can occur repeatedly, indicating a very high organ regenerative capacity, which is in contrast to most other parenchymal organs such as kidney or pancreas (Stocker et al., 1973) . The role of liver stem cells in regeneration has been controversial (Alison et al., 1997; Fausto, 1994; Sell, 1994; Sell and Ilic, 1997; Thorgeirsson, 1996) , but many of the disagreements in the field can be reconciled by considering the different experimental conditions which have been used to study the process. Liver stem cells can be defined in several different ways which are listed in Table 1 . Current evidence strongly suggests that different cell types and mechanisms are responsible for organ reconstitution depending on the type of liver injury. In addition, tissue replacement by endogenous cells ( ¼ regeneration) must be distinguished from reconstitution by transplanted donor cells ( ¼ repopulation).
Hepatic oval cells
In most settings of liver injury, the pre-existing differentiated hepatocytes display their regenerative ability and divide to replace lost cells. Therefore this type of liver regeneration is progenitor independent. However, it has been appreciated for some time that liver regeneration can also be driven by non-hepatocyte cells under certain experimental conditions. The cells which proliferate in this progenitor dependent type of regeneration are located near the portal triad of the liver lobule in the Canal of Hering. After the initial rounds of proliferation these cells then give rise to small cells with a high nuclear/cytoplasmic ratio. These small cells which eventually become differentiated hepatocytes are termed oval cells because of their morphology (Shinozuka et al., 1978) . In the rat, chronic liver injury by chemicals such as DL-ethionine, galactosamine and azo dyes represent examples of this type of liver damage. The toxic drugs are often combined with surgical partial hepatectomy. Many of the compounds which induce oval cell proliferation are DNA damaging agents. A common feature of progenitor-dependent liver regeneration is that the hepatocytes themselves cannot divide normally. Thus, progenitor-dependent regeneration may be utilized when parenchymal hepatocytes are severely damaged on a chronic basis and/or unable to regenerate efficiently. Oval cells express markers of both bile-duct epithelium (CK19) and hepatocytes (albumin). In addition, in the rat they express high levels of a-fetoprotein and are thus similar to fetal hepatoblasts in their gene expression profile (Shinozuka et al., 1978) . Furthermore, oval cells are bipotential Mechanisms of Development 120 (2003) [99] [100] [101] [102] [103] [104] [105] [106] and retain the ability to differentiate into both the bile duct epithelial and hepatocyte lineages in vitro (Sirica, 1995; Sirica et al., 1990) . Because of their similarity to hepatoblasts and their bipotential capacity oval cells have been considered early progenitors in analogy to committed hematopoietic progenitors.
Oval cells have been delineated best in several rat models of injury and several monoclonal antibodies have been generated against these cells (Hixson et al., 1997a (Hixson et al., ,b, 2000 . In addition, oval cells have been shown to express some known surface antigen, particularly the c-kit receptor (Fujio et al., 1994; Omori et al., 1997) and the Thy-1 antigen (Petersen et al., 1998) . Interestingly, both of these markers are also expressed on hematopoietic stem cells.
Oval cell proliferation has also been described in a variety of human liver diseases, indicating that progenitor-dependent regeneration can be found in multiple organisms. Oval cells are found in disorders associated with chronic liver injury and are located at the edges of nodules in liver cirrhosis. As in the rat, OV6 is a useful marker for these cells in humans (Baumann et al., 1999; Crosby et al., 1998) . Interestingly, cells which are c-kit positive but negative for hematopoietic markers have also been identified in human pediatric liver disease (Baumann et al., 1999) .
Until recently it has been difficult until recently to induce oval cell proliferation in the mouse and take advantage of the powerful genetics in this organism. Using transgenic mice, it would be possible to determine whether factors known to be important in liver regeneration after partial hepatectomy are also required for oval cell driven regeneration. Now, however, several protocols have been developed which also result in progenitor-dependent hepatocyte regeneration in the mouse (Akhurst et al., 2001; Knight et al., 2000; Preisegger et al., 1999; Rosenberg et al., 2000) . One regimens utilizes cocaine 1 phenobarbital (Rosenberg et al., 2000) , another 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) (Preisegger et al., 1999 ) and a third a methionine deficient diet (Akhurst et al., 2001; Knight et al., 2000) . Mouse 'oval cells' differ from their rat and human counterparts by not expressing AFP. The rat monoclonal antibody OV6 does also not react with murine oval cells and to date only one oval cell-specific antibody, termed A6, has been developed for the mouse (Faktor et al., 1990) . Nonetheless, work on the genetics of oval cell proliferation is now possible. An example is the recent discovery using transgenic mice that TGF-b1 inhibits oval cell proliferation (Preisegger et al., 1999) . In addition, TNF-1 receptor also plays a role in this process (Knight et al., 2000) . Despite these recent studies, very little is currently known about the signaling mechanism(s) that govern oval cell proliferation.
It is important to emphasize that the oval cells themselves are not the earliest hepatic progenitors, but rather a committed progenitor, relatively late in the hierarchy. They derive from rare intrahepatic cells resident in the Canal of Hering about which very little is known. No information exists about cell surface markers, gene expression profiles and other properties of these. Some electron microscopic studies have identified morphological properties of candidate cells in this location (Novikoff et al., 1991 (Novikoff et al., , 1996 .
Hepatic cell types in the adult pancreas
Importantly for this review, the oval cells described above and hepatocytes themselves can be found not only in the liver, but are also in the pancreas in several mammalian animal models. As a group, these observations have to the hypothesis that the adult pancreas harbors hepatic precursors. The lineage relationships between pancreatic hepatocyte precursors, hepatic oval cells and precursors for other pancreatic cell types are the subject of ongoing investigation.
In embryonic development there is a close relationship between the liver and the pancreas, which is discussed elsewhere in this volume. Both organs develop from the ventral foregut endoderm at a similar time hence lending support to the hypothesis of a common precursor cell for the hepatic and pancreatic lineages (Deutsch et al., 2001 ).
Early studies
The earliest description of pancreatic hepatocytes was in hamsters treated with a pancreatic carcinogen, N-nitrosobis(2-oxopropyl)amine (BOP) in 1981 (Scarpelli and Rao, 1981) . Similarly, small, occasional clusters of hepatocytelike cells were also found in rats being treated with a peroxisome proliferators Wy-14643 (Lalwani et al., 1981) . Other carcinogenic regimens can also elicit the emergence of rare hepatocyte-like cells in the rat (Hoover and Poirier, 1986; McDonald and Boorman, 1989) . Interestingly, some of the same carcinogens can be used to produce hepatic oval cells, particularly when combined with partial hepatectomy. These studies clearly suggested that adult pancreas contained cells differentiating at least partially down the hepatocyte lineage.
Copper depletion in the rat
The best known example and most robust experimental model for the emergence of oval cells and hepatocyte like cells in copper depleted rats after re-feeding of copper (Rao et al., 1986 (Rao et al., , 1988 . Much has been learned from this system. In this system, weanling Fisher rats are fed a copper-free diet and the copper chelator triene for 6-9 weeks. This feeding regimen leads to near complete acinar atrophy so Table 1 Definitions of liver stem cells 1. Cells responsible for normal tissue turnover 2. Cells which give rise to regeneration after partial hepatectomy 3. Cells responsible for progenitor-dependent regeneration 4. Transplantable liver repopulating cells 5. Cells which result in hepatocyte and bile duct phenotypes in vitro that only pancreatic ducts and exocrine cells remain. After 6-8 weeks cells with multiple features of hepatic oval cells emerged. However, it is important to emphasize that the majority of these cells have phenotypic properties of oval cells and are not those of classic, mature hepatocytes. For example, they are AFP positive whereas differentiated hepatocytes are AFP negative. Interestingly, stem cell factor (SCF) appears to be involved in the proliferation of pancreatic oval cells, similar to those observed in the liver (Rao et al., 1996) . The morphologic studies performed in this system suggested that the oval cell precursors resided within or near the pancreatic ducts and possibly could be the duct cells themselves (Rao et al., 1989) . When copper is reintroduced into the diet after pancreatic oval cells have emerged, they can further differentiate and cells with multiple hepatocellular characteristics can develop. In some, but not all animals almost complete hepatization of the pancreas can be observed even macroscopically. The pancreatic hepatocytes occur in small clusters and express many genes typical for differentiated hepatocytes including albumin (Rao et al., 1989) , a 2u -globulin, carbamylphosphate synthetase and glutamine synthetase (Yeldandi et al., 1990) .
The signals covering the phenotypic transition of pancreatic cells to hepatocytes are not known at this point. However, the observations suggest that the absence of pancreatic exocrine cells may be responsible for the emergence of the hepatic lineages. This leads to a model in which pancreatic exocrine cells produce an inhibitory signal, which represses the hepatocyte fate in normal pancreas. This inhibitory signal could be dependent on direct cell contact or a secreted factor made by intact exocrine cells. The authors of these classic studies were the first to suggest the presence of a pancreatic liver stem cell in adult animals (Reddy et al., 1991) .
Recently, pancreatic oval cells induced by copper depletion in wild-type rats were enriched by Nycodenz gradient and then transplanted into the liver of dipeptidyl peptidase IV (DPPIV) deficient rats (Dabeva et al., 1997) . DPPIV is a marker, which is produced by both hepatocytes and mature bile ducts and can therefore be used to detect cells of these lineages in the DPPIV negative animals. Copper depletion resulted in small cells (8-10 mm) that were both albuminand DPPIV-positive. These cells were transplanted into the spleens of DPPIV negative rats and 4 weeks after transplantation, the pancreatic oval cells had appeared to differentiate into mature hepatocytes. As a control hepatic oval cells induced by d-galactosamine (Lemire et al., 1991) were also transplanted. The hepatocytes derived from pancreatic oval cells were morphologically and functionally indistinguishable from those produced by liver oval cells (Dabeva and Shafritz, 1993) .
Unfortunately, the copper depletion protocol described above appears to be specific to rats. Our laboratory has tested the same copper-depleted diet in several mouse strains and not been able to achieve acinar cell ablation or oval cell proliferation similar to that seen in the rat.
Pancreatic oval cells in keratinocyte growth factor (KGF) transgenic mice
Although copper depletion cannot induce oval cell proliferation in the murine pancreas, a transgenic mouse model with pancreatic oval cells has been described (Krakowski et al., 1999a) . These mice harbor a transgene in which KGF is expressed under the transcriptional control of the insulin promoter and is therefore made at high concentrations in and near islets. KGF is a cytokine that has growth promoting properties for multiple epithelial cell types. The insulin-KGF transgenics were developed as part of an effort to discover growth factors that could promote the expansion of pancreatic b-cell precursors. While b-cell was not affected in the transgenics, oval cells with typical features of hepatocellular differentiation emerged. These cells expressed AFP and albumin and in addition resembled hepatocytes morphologically. The number of oval cells increased with time and about 20% of islets contained hepatocytes after 1 year of age (Krakowski et al., 1999a) . Another feature of this model is the proliferation of intraislet ducts, presumably due to the mitogenic effects of KGF. Nonetheless, no lineage relationship between the ducts and pancreatic hepatocytes could be discerned. This experiment suggests that KGF may be one of the factors capable of inducing pancreatic progenitor cells to take of the hepatocyte fate.
Another transgenic mouse developed by the same laboratory for studies of pancreatic b-cell precursors shed additional light on the cytokines involved in controlling the fate of pancreatic liver precursors. Epidermal growth factor, driven by an insulin promoter suppressed the emergence of KGF induced oval cells (Krakowski et al., 1999b) . In mice, which carried both an insulin-KGF and insulin-EGF transgene, no pancreatic oval cells were found.
Liver repopulation with pancreatic cell suspensions
An in vivo repopulation assay for the liver similar to hematopoietic reconstitution of irradiated animals was first described in 1994 (Rhim et al., 1994) . Transgenic mice expressing urokinase from the hepatocyte-specific albumin promoter develop severe liver disease, but could be rescued by transplantation of non-transgenic hepatocytes. This first system had some practical limitations including urokinase induced bleeding, the need to transplant very young mice and spontaneous repopulation by hepatocytes with had lost the transgene (Rhim et al., 1994; Sandgren et al., 1991) . Since the initial reports, several other systems have been described (reviewed in (Shafritz et al., 2001) ). Mice with a knockout of the tyrosine catabolic enzyme fumarylacetoacetate hydrolase (FAH) were developed by this laboratory (Grompe et al., 1993) and represent a second model for liver repopulation with many advantages. FAH mutants develop severe liver disease which can rescued by blocking the tyrosine pathway upstream using the drug of 2-(2-nitro-4-trifluoro-methylben-zyol)-1,3 cyclohexanedione (NTBC) (Grompe et al., 1995) . Thus, FAH mutants develop to adulthood, can breed and remain healthy until NTBC is removed. After NTBC withdrawal liver failure occurs and the mice die within 6-8 weeks. When FAH mutant mice are transplanted intrasplenically with single cell suspensions of syngeneic hepatocytes from wild-type mice, the FAH-positive cells migrate to the liver, invade the parenchyma and divide until . 95% of the liver cell mass is replaced by donor cells (Overturf et al., 1996) . Repopulated animals are healthy. As few as 100 donor cells are sufficient for phenotypic rescue. Thus, the FAH mutant mouse represents a very robust assay system for the identification of cells with hepatocellular differentiation capacity. Moreover, repopulating cells can be serially transplanted to measure their cell division capacity (Overturf et al., 1997) . Cell sorting experiments have been carried out to identify those cells with the highest regenerative capacity (Overturf et al., 1999) .
Recently is has been shown that adult mouse bone marrow (Lagasse et al., 2000) and pancreas (Wang et al., 2001 ) also contain cells capable of liver repopulation in this system. The pancreatic cell transplantation experiments were conceived as a way to demonstrate that liver repopulation could be affected by hepatocyte precursors and not only hepatocytes themselves. The literature regarding pancreatic oval cells (see above) suggested that hepatocyte progenitors might indeed exist in adult mouse liver and could be detected in the FAH deficient mouse model. For this reason, the pancreata of mice wild-type for FAH, but transgenic for E. coli lacZ were digested into single cells and then transplanted into FAH mutant mice. Importantly, the cells used in these experiments were from normal adult pancreata. No chemical treatments or oval cell induction regimens were used to treat the donor mice. A large number of transplantations were carried out and recipient mice were either harvested early (4 weeks after transplant) or late (2 months after transplant or later). The early time-points were to estimate the frequency of hepatocyte precursors in mouse pancreas. The late time-points were to determine whether adult mouse pancreas contained cells that could actually phenotypically rescue FAH mutant mice and prevent their death from liver disease. Although only ,10% of pancreas cell transplanted FAH mutant mice survived long-term and had extensive liver repopulation, these few animals (total of six in our study) demonstrated convincingly for the first time that the pancreas contains cells which can give rise to completely functional and normal hepatocytes (Wang et al., 2001) . Previous studies had demonstrated cells with multiple hepatocellular markers (Dabeva et al., 1997) , but never shown that they were actually true hepatocytes capable of correcting liver disease. The early harvest time-points showed pancreas-derived hepatocytes in a larger proportion of animals (.50%). Based on the number of hepatocyte nodules formed it could be estimated that pancreatic liver precursors were rare. ,1/5000 transplanted cells formed a hepatocyte nodule (Fig. 1) .
Additional experiments were carried out to determine whether pancreatic duct cells were the hepatocyte precursors. Two approaches were taken. First, the crude preparations of pancreatic ducts were enriched for duct cells before transplantation. Second, primary cultures of pancreatic duct cells were established and transplanted after several weeks of primary culture. Both experiments showed that the pancreatic ducts themselves did not give rise to hepatocytes in the liver repopulation assay. These findings are not inconsistent with the results obtained with the copper depletion model, because both periductular, interstitial cells as well as the ducts themselves were considered candidates to be oval cell precursors (Rao et al., 1989) .
The results obtained in these transplantation experiments strongly indicate that hepatocyte precursors exist in the normal adult mouse pancreas and that duct cells are not the precursor population.
Pancreas-derived cell lines
Several laboratories have produced cell lines from the adult pancreas and used them in transdifferentiation studies. In one study permanent cell lines with epithelial characteristics were established from both liver and pancreas under similar culture conditions (Bisgaard and Thorgeirsson, 1991) . Extensive phenotypical characterization was performed and under the conditions of analysis none of the cell lines expressed differentiated markers of either pancreas or liver. However, their morphological characteristics and expression profiles for aldolase, lactate dehydrogenase and cytokeratins were indistinguishable (Bisgaard and Thorgeirsson, 1991) suggesting that primitive epithelial cells from both organs were very similar.
Others established permanent 'duct' epithelial cell lines also from the rat which expressed cytokeratins 8 and 19 and carbonic anhydrase (Chen et al., 1995) . These cells were then implanted in a collagen matrix into normal rat, either subcutaneously or into the peritoneal cavity. Upon transplantation, several hepatocyte-specific markers were expressed and pancreatic duct markers were silenced. This was particularly true for those cells transplanted into the mesenteric fat pad. The expression levels of albumin, transferrin and aldolase B approached those seen in normal adult hepatocytes. Again, these data are consistent with the hypothesis that adult pancreas contains hepatocyte precursors.
Pancreatic cell phenotypes in the liver
If the adult pancreas contains hepatocyte precursors, it seems reasonable to hypothesize that liver-resident precursors may be capable of differentiating into pancreatic cell types. Although reports of 'hepatic pancreatocytes' exist, these observations are less numerous in the literature. The examples of pancreatic differentiation of liver cells will be discussed in the following.
Pancreatic markers in liver cancer
Some cases of liver tumors, particularly cholangiocarcinomas, display expression of markers typical for pancreatic cell types (Hruban et al., 1987; Terada and Nakanuma, 1995) . In one small series of liver tumors analyzed 61% of cholangiocarcinomas expressed pancreatic type amylase (Terada and Nakanuma, 1995) . Other tumors have been reported to produce lipase, another enzyme specific for pancreatic exocrine cells (Hruban et al., 1987) .
Pancreatic marker expression in liver oval cell lines
One recent paper showed that cultured rat oval cell lines could be differentiated in vitro into cells with regulated insulin secretion, i.e. properties similar to pancreatic bcells. These cells were even able to rescue one diabetic rat in transplantation experiments (Yang et al., 2002) . Similar results were also reported by another group in abstract form at an NIH conference on pancreatic stem cells (Yin et al., 2001 ).
Pancreatic markers in sorted fetal liver cell populations
A very recent report described elegant work in which fetal mouse liver cells were fractionated by FACS and analyzed for their proliferative as well as differentiation capacity (Suzuki et al., 2002) . A multi-potent population of cells was identified in ED 13.5 mouse liver. These cells were characterized as c-kit
2 , c-met
. In vitro they proliferated extensively and could be differentiated into either hepatocytic or biliary lineages. However, the same cells could also express multiple pancreatic markers when cultured long-term or transplanted into a pancreatic environment in vivo. The genes expressed in vitro included endocrine markers (preproinsulin, preproglucagon) , pancreas specific transcription factors (pdx-1, pax6) and exocrine markers (amylase-2, lipase). The same group presented a recent abstract where a similar sorting approach had been applied to neonatal mouse pancreas (Suzuki et al., 2001) . The c-kit
1/low cells from pancreas were able to be differentiated into hepatoctyes in vitro.
Summary and conclusions
The existence of pancreatic liver precursors has been shown in several different mammalian species and under multiple experimental conditions. Similarly it has been shown that the adult liver contains cells that take on pancreatic cell fates. It can be therefore hypothesized that both adult liver and adult pancreas continue to harbor a small population of primitive hepatopancreatic stem cells with the potential to give rise to the same differentiated progeny as during embryogenesis. A hypothetical scheme depicting this hypothesis is shown in Fig. 2 .
It is important to acknowledge that an alternative explanation for the observed phenomena also exists. Hepatic differentiation of pancreatic cells and pancreatic differentiation of liver cells may could represent transdifferentiation of common, adult cell types rather than differentiation of a common stem cell. This may be especially true for some of the phenotypic transitions observed in tissue culture experiments. For example it has clearly been shown that a pancreatic cell line with exocrine properties can differentiated to hepatocyte-like cells in vitro (Shen et al., 2000) . Although, transdifferentiation is -in my opinion -an unlikely explanation for most of the in vivo data, the stem cell hypothesis remains to be rigidly proven by clonal isolation of the cell and its definitive characterization. Many questions for future investigation remain. What is the nature of the putative hepatopancreatic stem cell? Where is it anatomically located? What genes does it express? What is its frequency? What role does it play in the regenerative responses of pancreas and liver? What kinds of developmental potential does it have, especially towards the pancreatic endocrine lineage? The answers to all of these questions will likely require their isolation and purification to homogeneity at the single cell (clonal) level.
To date, sorting and analysis of dispersed single pancreatic cells has not been reported in the literature and thus very little knowledge exists about the behavior of pancreatic cells at the single cell level. In addition, the purification of stem cells requires a reliable assay for their detection. Two basic approaches towards this problem exist. The first is to use an vitro differentiation assay and determine whether the purified cell population can give rise to the desired differentiated progeny (in particular b-cells). This approach has been applied for example to the enrichment of neural crest stem cells (Morrison et al., 1999) , but to date no robust method for the induction of b-cell differentiation in vitro from precursors has been described. Currently therefore, pancreatic precursor cells have not been purified or isolated from adult pancreas in any species. The second approach for the isolation of stem cells is more direct and involves repopulation of the target organ as the assay. The hematopoietic stem cell was isolated by using multi-lineage repopulation of lethally irradiated recipients as the assay (Spangrude et al., 1988) . Unfortunately, the absence of insulin or b-cells alone is not a sufficient stimulus for islet-cell neogenesis and thus the repopulation of islet-cell depleted pancreata and restoration of insulin secretion cannot be utilized as a transplantation assay for pancreatic b-cell precursors. Thus, to date neither an vitro or a transplantation based assay for the desired cell population currently exist.
Several laboratories have started working on the prospective isolation of hepatic and pancreatic stem cells based on in vitro analysis of sorted cells. Approaches similar to those recently reported by Suzuki et. al. may lead to some enrichment (Suzuki et al., 2001 (Suzuki et al., , 2002 . Similarly, the liver repopulation assay in the FAH knockout mouse (Wang et al., 2001) offers the opportunity to purify pancreatic hepatocyte precursors from adult and fetal animals. For both approaches the enrichment of cells using single cell sorting techniques will be needed. Unfortunately, no pancreas or liver-specific reagents for cell sorting are currently available. Monoclonal antibodies against cell surface antigens of these cell types do not exist, but will almost certainly be necessary to make progress in the isolation of pancreatic stem cells.
Once the stem cells can be purified the next challenge will be to understand the signaling networks that initiate and stabilize their potential cell fates. It will be desirable to expand progenitors in vitro and then differentiate them into specific lineages. The biology learned from animal systems can then be tried in human cell sources and medical applications. It can be hoped that this approach will yield functional b-cells, hepatocytes and possibly other cell types for therapeutic cell transplantation.
